Xeltis

Driving breakthroughs in vascular implants

Xeltis is a medtech company developing transformative vascular implants that enable the natural creation of living and long-lasting tissue.

Leveraging its proprietary endogenous tissue restoration (ETR) platform, Xeltis seeks to address the limitations of currently available options for the millions of people requiring hemodialysis vascular access or cardiovascular replacements every year.